Predicting Future Outcomes from Kidney Biopsies with MCD/FSGS Lesions: Opportunities and Limitations
- PMID: 35728879
- PMCID: PMC9257806
- DOI: 10.1681/ASN.2022040506
Predicting Future Outcomes from Kidney Biopsies with MCD/FSGS Lesions: Opportunities and Limitations
Keywords: focal segmental glomerulosclerosis; human genetics; nephrotic syndrome; pathophysiology of kidney disease and progression; proteinuria.
Figures
Comment on
-
Kidney Biopsy Features Most Predictive of Clinical Outcomes in the Spectrum of Minimal Change Disease and Focal Segmental Glomerulosclerosis.J Am Soc Nephrol. 2022 Jul;33(7):1411-1426. doi: 10.1681/ASN.2021101396. Epub 2022 May 17. J Am Soc Nephrol. 2022. PMID: 35581011 Free PMC article.
References
-
- Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, et al. ; IgAN Classification Working Group of the International IgA Nephropathy Network and the Renal Pathology Society; Conference Participants : Oxford classification of IgA nephropathy 2016: An update from the IgA Nephropathy Classification Working Group. Kidney Int 91: 1014–1021, 2017 - PubMed
-
- KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases : Kidney Int Suppl 100: S1–S276, 2021. Available at https://www.kidney-international.org/article/S0085-2538(21)00562-7/fulltext. Accessed May 26, 2021 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
